Conifer Holdings Valuation
Is CNFR undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Analyst Forecast
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CNFR?
Other financial metrics that can be useful for relative valuation.
| What is CNFR's n/a Ratio? | |
|---|---|
| n/a Ratio | 0x |
| n/a | n/a |
| Market Cap | US$19.56m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.3x |
| Enterprise Value/EBITDA | -2.5x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does CNFR's PS Ratio compare to its peers?
| Company | PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 7.6x | ||
PPHI Positive Physicians Holdings | 1.1x | n/a | US$24.0m |
KINS Kingstone Companies | 0.1x | -7.2% | US$14.1m |
ACMT.A ACMAT | 28.5x | n/a | US$25.8m |
ICCH ICC Holdings | 0.7x | n/a | US$51.7m |
CNFR Conifer Holdings | 0.2x | 1.7% | US$19.6m |
Price-To-Sales vs Peers: CNFR is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (7.6x).
Price to Earnings Ratio vs Industry
How does CNFR's PE Ratio compare vs other companies in the US Insurance Industry?
Price-To-Sales vs Industry: CNFR is good value based on its Price-To-Sales Ratio (0.2x) compared to the US Insurance industry average (0.9x)
Price to Sales Ratio vs Fair Ratio
What is CNFR's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.2x |
| Fair PS Ratio | 0.2x |
Price-To-Sales vs Fair Ratio: CNFR is good value based on its Price-To-Sales Ratio (0.2x) compared to the estimated Fair Price-To-Sales Ratio (0.2x).
Share Price vs Fair Value
What is the Fair Price of CNFR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate CNFR's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate CNFR's fair value for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.